These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30099725)

  • 41. The ALS disease protein TDP-43 is actively transported in motor neuron axons and regulates axon outgrowth.
    Fallini C; Bassell GJ; Rossoll W
    Hum Mol Genet; 2012 Aug; 21(16):3703-18. PubMed ID: 22641816
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aberrant assembly of RNA recognition motif 1 links to pathogenic conversion of TAR DNA-binding protein of 43 kDa (TDP-43).
    Shodai A; Morimura T; Ido A; Uchida T; Ayaki T; Takahashi R; Kitazawa S; Suzuki S; Shirouzu M; Kigawa T; Muto Y; Yokoyama S; Takahashi R; Kitahara R; Ito H; Fujiwara N; Urushitani M
    J Biol Chem; 2013 May; 288(21):14886-905. PubMed ID: 23558684
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43).
    Bentmann E; Neumann M; Tahirovic S; Rodde R; Dormann D; Haass C
    J Biol Chem; 2012 Jun; 287(27):23079-94. PubMed ID: 22563080
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity.
    Johnson BS; Snead D; Lee JJ; McCaffery JM; Shorter J; Gitler AD
    J Biol Chem; 2009 Jul; 284(30):20329-39. PubMed ID: 19465477
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prion-like properties of pathological TDP-43 aggregates from diseased brains.
    Nonaka T; Masuda-Suzukake M; Arai T; Hasegawa Y; Akatsu H; Obi T; Yoshida M; Murayama S; Mann DM; Akiyama H; Hasegawa M
    Cell Rep; 2013 Jul; 4(1):124-34. PubMed ID: 23831027
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
    Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
    Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pathological TDP-43 changes in Betz cells differ from those in bulbar and spinal α-motoneurons in sporadic amyotrophic lateral sclerosis.
    Braak H; Ludolph AC; Neumann M; Ravits J; Del Tredici K
    Acta Neuropathol; 2017 Jan; 133(1):79-90. PubMed ID: 27757524
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytoplasmic accumulation of TDP-43 in circulating lymphomonocytes of ALS patients with and without TARDBP mutations.
    De Marco G; Lupino E; Calvo A; Moglia C; Buccinnà B; Grifoni S; Ramondetti C; Lomartire A; Rinaudo MT; Piccinini M; Giordana MT; Chiò A
    Acta Neuropathol; 2011 May; 121(5):611-22. PubMed ID: 21120508
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutations in the ubiquitin-binding domain of OPTN/optineurin interfere with autophagy-mediated degradation of misfolded proteins by a dominant-negative mechanism.
    Shen WC; Li HY; Chen GC; Chern Y; Tu PH
    Autophagy; 2015 Apr; 11(4):685-700. PubMed ID: 25484089
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CUL2-mediated clearance of misfolded TDP-43 is paradoxically affected by VHL in oligodendrocytes in ALS.
    Uchida T; Tamaki Y; Ayaki T; Shodai A; Kaji S; Morimura T; Banno Y; Nishitsuji K; Sakashita N; Maki T; Yamashita H; Ito H; Takahashi R; Urushitani M
    Sci Rep; 2016 Jan; 6():19118. PubMed ID: 26751167
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection and quantification of novel C-terminal TDP-43 fragments in ALS-TDP.
    Feneberg E; Charles PD; Finelli MJ; Scott C; Kessler BM; Fischer R; Ansorge O; Gray E; Talbot K; Turner MR
    Brain Pathol; 2021 Jul; 31(4):e12923. PubMed ID: 33300249
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of alternative isoforms and inclusion body of the TAR DNA-binding protein-43.
    Nishimoto Y; Ito D; Yagi T; Nihei Y; Tsunoda Y; Suzuki N
    J Biol Chem; 2010 Jan; 285(1):608-19. PubMed ID: 19887443
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TDP-43 aggregation in neurodegeneration: are stress granules the key?
    Dewey CM; Cenik B; Sephton CF; Johnson BA; Herz J; Yu G
    Brain Res; 2012 Jun; 1462():16-25. PubMed ID: 22405725
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.
    Yamashita T; Kwak S
    Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oxr1 improves pathogenic cellular features of ALS-associated FUS and TDP-43 mutations.
    Finelli MJ; Liu KX; Wu Y; Oliver PL; Davies KE
    Hum Mol Genet; 2015 Jun; 24(12):3529-44. PubMed ID: 25792726
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rab1-dependent ER-Golgi transport dysfunction is a common pathogenic mechanism in SOD1, TDP-43 and FUS-associated ALS.
    Soo KY; Halloran M; Sundaramoorthy V; Parakh S; Toth RP; Southam KA; McLean CA; Lock P; King A; Farg MA; Atkin JD
    Acta Neuropathol; 2015 Nov; 130(5):679-97. PubMed ID: 26298469
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The molecular mechanisms of intracellular TDP-43 aggregates].
    Nonaka T; Arai T; Hasegawa M
    Brain Nerve; 2009 Nov; 61(11):1292-300. PubMed ID: 19938686
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of TDP-43 C-terminal Fragments in Vitro Recapitulates Pathological Features of TDP-43 Proteinopathies.
    Igaz LM; Kwong LK; Chen-Plotkin A; Winton MJ; Unger TL; Xu Y; Neumann M; Trojanowski JQ; Lee VM
    J Biol Chem; 2009 Mar; 284(13):8516-24. PubMed ID: 19164285
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The amyloidogenicity of a C-terminal region of TDP-43 implicated in Amyotrophic Lateral Sclerosis can be affected by anions, acetylation and homodimerization.
    Prasad A; Sivalingam V; Bharathi V; Girdhar A; Patel BK
    Biochimie; 2018 Jul; 150():76-87. PubMed ID: 29751083
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TDP-43 N-terminal domain dimerisation or spatial separation by RNA binding decreases its propensity to aggregate.
    Miura M; Sakaue F; Matsuno H; Morita K; Yoshida A; Hara RI; Nishimura R; Nishida Y; Yokogawa M; Osawa M; Yokota T
    FEBS Lett; 2023 Jun; 597(12):1667-1676. PubMed ID: 37177801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.